The patent summary says, „The invention provides the isolated human Ebola (hEbola) viruses denoted as Bundibugyo (EboBun) deposited with the Centers for Disease Control and Prevention („CDC“; Atlanta, Georgia, United States of America) on November 26, 2007 and accorded an accession number 200706291.“